ASCO Tumor Boards: Metastatic Colon Cancer

This is a case-based activity that includes discussion of a 69-year-old woman with positive fecal occult blood test (FOBT), who underwent a colonoscopy showing hepatic flexure adenocarcinoma. The patient then underwent hemicolectomy, staging pT3 N2 cM0. 

Learning Objectives

After participating in this course, learners will be better able to:

  • Examine the important clinical and molecular subgroups of advanced colorectal cancer
  • Explain the relevance of extended RAS mutations and BRAF beyond KRAS exon 2 in current practice
  • Determine the impact of side of primary on prognosis and treatment choice
  • Discuss the additional mutations beyond RAS and RAF, i.e. Her 2, MSI/dMMR, and impact on therapy

Continuing Education Credit: 1.5 Credits/Points are available for participation in this course. Certificate and credit types include:

  • AMA PRA Category 1 Credits
  • ABIM MOC Points
  • CNE Contact Hours
  • CPE Credits
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted. Certificate of Completion may be used to document participation, but no credit will be conferred.

Important Notes: This course expires on March 29, 2020. Learners must complete all necessary course components by this date. This course is available as part of the 2018 ASCO Tumor Boards bundle.